Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
JNNP 100
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
JNNP 100
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 95, Issue 9
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer’s disease
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Neurodegeneration
Original research
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer’s disease
Online download statistics by month:
Online download statistics by month: June 2024 to September 2024
Abstract
Full
Pdf
Jun 2024
1353
1315
391
Jul 2024
557
542
167
Aug 2024
1161
1170
251
Sep 2024
771
756
135
Total
3842
3783
944
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF